In response to vaccine injuries linked to the HPV vaccines Gardasil and Cervarix, 12 plaintiffs in Japan plan to file a class action lawsuit against the Japanese government, Merck and GlaxoSmithKine after June 2016. The plaintiffs are seeking answers about why they were not told about the HPV vaccine risks before they received the vaccination.
As it currently stands, Japan’s Ministry of Health, Labor and Welfare has advised local governments not to actively promote HPV vaccine use. In fact, the health ministry reversed their HPV vaccination recommendation in 2013 after HPV vaccine recipients began experiencing horrible side effects including everything from paralysis to short-term memory loss.
But despite the fact that Japan’s health ministry withdrew their HPV vaccine recommendation and Japanese girls have experienced adverse reactions after receiving the vaccination, HPV vaccines are still on the market in the country. You read correctly – they’re still available in Japan; girls can opt to receive the HPV vaccine if they are so inclined. However, vaccine providers and doctors must convey to these girls that getting this shot is not recommended by the health ministry.
Enter the aforementioned lawsuit where plaintiffs are demanding to know why they weren’t informed of the negative side effects of the HPV vaccine prior to getting it.
Read more at: